Friday February 22, 2019 07:38

Heathcare Press Release : 14 Sep 2016

Saxenda(R) Provides Consistent Weight Loss and Improvements in Blood Glucose Control Across BMI Heathcare—14 Sep 16

Results from a post hoc analysis of the three-year part of the phase 3a SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial show that people treated with Saxenda(R) (liraglutide 3 mg) experienced consistent weight